Relmada plans NDV-01 IND by end of 2026 as cash runway extends through 2029 — See source for full details.
$RLMD
Price history, market instrument context, member research, and related headlines in one place.
RLMD key statistics
NasdaqCMUSD
52-week range
$1.8023%$8.00
Latest session $3.20–$3.37Relmada Therapeutics, Inc. (RLMD) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $3.24, down $0.12 (3.57%) from the previous close of $3.36. It has traded between $3.20 and $3.37 in the latest session. Over the past year it has ranged from $1.80 to $8.00, leaving it in the lower quarter of its 52-week range (23%). Reported volume for the session was 1.4M. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $RLMD research…